Dr Luis Aznar Publications

Peer-reviewed publications

· Stereotactic Magnetic Resonance-Guided Daily Adaptive SABR (SMART) for Localised Non-Metastatic Pancreatic Cancer: First Reported Clinical Outcomes From the UK. K. Nugent, S. Mukherjee, S. Teoh, B. George, A. Martin, A. Gaya, L. Aznar-Garcia K. Chu, M. Robinson, T. Maughan, J. Good. Clinical Oncology 36 (2024) 576-584.

· Liver metastases treated with SABR. Single centre experience. Lauren Jones and Luis Aznar. ESTRO Vienna, 2023.

· SABR in pancreatic cancer. Experience at NUH. Lauren Jones and Luis Aznar. SABR Consortium UK, 2023.

· SABR in HCC at NUH. Lauren Jones and Luis Aznar. SABR Consortium UK, 2023.

· SABR in liver metastases. Lauren Jones and Luis Aznar. SABR Consortium UK, 2023.

· Implementing 2# SABR for symptomatic spine metastases. Kyle Woods, Luis Aznar Garcia, John Conibear, Veni Ezhil, Philip Camilleri, Alex Martin, James Good, Paul Laycock. SABR Consortium UK, 2022.

· Adaptive MR-guided stereotactic ablative radiotherapy for pancreatic cancer – first UK experience. James Good, Ben George, Suliana Teoh, Adam Nash, Andrew Gaya, Robert Owens, Luis Aznar-Garcia, Maxwell Robinson, Alex Martin, Kwun-Ye Chu, Somnath Mukherjee, Tim Maughan. SABR Consortium UK, 2022.

· Multi-Platform Decision Making for SABR Patients in Genesis Care. Paul Laycock, Jamie Mills and Luis Aznar-Garcia. SABR Consortium UK, 2022.

· Early experience on MR-guided SABR for central and ultra-central mediastinal lymph nodes. Alex Martin, John Connibear, Veni Ezhil, Ben George, Hannah Wright, Luis Aznar-Garcia, Andy Gaya and James Good. SABR Consortium UK, 2022.

· Interval between MRI and SRS is associated with local control in lung squamous cell brain metastasis. J.W. Ho, L Aznar Garcia, J. Christian and P. Patel. August 2021. Radiotherapy and Oncology 161:S566. DOI: 10.1016/S0167-8140(21)07015-8

· The use of teleconsultations in a regional Stereotactic Radiosurgery service: A pilot study. July 2019. JMIR Formative Research. O’Cathail M, Aznar L, Sivanandan MA, Christian J. DOI: 10.2196/15598.

· Bringing specialist radiotherapy to the patient: The use of teleconsultations in a regional Stereotactic Radiosurgery service. July 2019. O’Cathail M, Aznar L, Sivanandan MA, Christian J. DOI: 10.2196/preprints.15598.

· 21-Day and Greater Interval Between Planning MRI And Stereotactic Radiosurgery Is Associated With Shorter Progression Free Survival In Patients With Three Or More Brain Metastasis. Ho J and Aznar L. November 2020. International Journal of Radiation Oncology Biology Physics 108(3):e704-e705. DOI: 10.1016/j.ijrobp.2020.07.065

· Motor and Executive Function Outcomes after Stereotactic Radiosurgery to Brain Metastases. Ho J and Aznar L. November 2020. International Journal of Radiation Oncology Biology Physics 108(3):e667. DOI: 10.1016/j.ijrobp.2020.07.1995

· High Initial Brain Metastasis Velocity Is Associated With Shorter Brain Progression Free Survival After Stereotactic Radiosurgery For Brain Metastases. Ho J and Aznar L. November 2020. International Journal of Radiation Oncology Biology Physics 108(3):e713. DOI: 10.1016/j.ijrobp.2020.07.084.

· Patterns of acute brain metastases related admissions: Opportunity amongst recurring themes. Bentley R, O’Cathail M, Aznar L, Crosby Vincent, Wilcock A, Christian Judy. April 2019. Radiotherapy and Oncology 133:S893-S894. DOI: 10.1016/S0167-8140(19)32080-8.

· The patterns of care and management of brain metastases In a large Oncology centre. Micheal O’Cathail, Luis Aznar, Rebecca Bentley, Vincent Crosby and Judith A. Christian. April 2019. Radiotherapy and Oncology 133:S685-S686. DOI: 10.1016/S0167-8140(19)31667-6.

· Teleconsultations: Bringing specialist radiotherapy services to patients. Micheal O’Cathail, Luis Aznar, Rebecca Bentley, Vincent Crosby and Judith A. Christian April 2019. Radiotherapy and Oncology 133:S894. DOI: 10.1016/S0167-8140(19)32081-X

· Defining patterns of care in the management of patients with brain metastases in a large oncology centre: A single‐centre retrospective audit of 236 cases. Bentley R, O’Cathail M, Aznar L, Crosby Vincent, Wilcock A, Christian Judy .April 2019. European Journal of Cancer Care 28(9). DOI: 10.1111/ecc.13059

· Stereotactic Radiosurgery for Brain Oligometastases: a One-year Single Centre Experience. J Ho, M O’Cathail, R Clements, L Aznar. June 2018. Clinical Oncology 30(6):e64. DOI: 10.1016/j.clon.2018.02.060

· SABR/SBRT for oligometastatic cancer within NHS commissioning through evaluation program—a single centre experience. Xin Chen-Zhao, Thiagarajan Sridhar and Luis Aznar. Aug 2018.·

· A planning comparison study implementing “AAA” heterogeneity calculation algorithm for stage II/III non-small cell lung cancer (NSCLC): is IMRT always the solution?. Luis Aznar, S. Wright, K. Coppock and Samreen Ahmed. Jan 2015. Lung cancer (Amsterdam, Netherlands).

·· Simultaneous cone beam computed tomography (SCBCT) acquisition during volumetric modulated arc therapy (VMAT) for stereotactic ablative radiotherapy (SART): a clinical quality assurance method with simultaneous and periradiotherapy CBCT-IGRT. Luis Aznar, A. Morenc, T. Sridhar and Samreen Ahmed. Jan 2015. Lung cancer (Amsterdam, Netherlands).

· · The impact of an inpatient acute oncology service on new lung cancer diagnoses. S. Ayub, A. Law, T. Sridhar, L Aznar and S.I. Ahmed. Jan 2016. Lung cancer (Amsterdam, Netherlands)..

·· Dosimetric findings in patients with moderate to severe late toxicity following SABR for lung cancer. Luis Aznar, Kerstie Johnson, A. Morenc and T. Sridhar. Jan 2016. Lung cancer (Amsterdam, Netherlands).

·· Dosimetric evaluation of adaptive planning during radiotherapy (ART) in radical lung to ensure tumour coverage and/or minimise doses to organs at risk – case discussion. A. Morenc, Kerstie Johnson, T. Sridhar and Luis Aznar. Jan 2016. Lung cancer (Amsterdam, Netherlands).

· · An audit of a single center use of SABR in primary lung cancer patients. Kerstie Johnson, S.U. Rahman, T. Sridhar, Luis Aznar. Jan 2016. Lung cancer (Amsterdam, Netherlands).

· · Relationship of dosimetric findings and toxicity following SABR for lung cancer. Kerstie Johnson, A. Morenc, T. Sridhar and Luis Aznar. Apr 2016. Radiotherapy and Oncology..

· · Relationship of dosimetric findings and toxicity following SABR for lung cancer. Kerstie Johnson, A. Morenc, T. Sridhar and Luis Aznar. Apr 2016. Radiotherapy and Oncology.

· · The impact of an acute oncology service on new lung cancer diagnoses. H.S. Walter, A. Law, C. Bunn. Luis Aznar and Sakawe Ahmed. Jan 2015. Lung cancer (Amsterdam, Netherlands).

·· “Effects of sodium bicarbonate supplementation on axial and peripheral bone mass in rats on strenuous treadmill training exercise. Rico H, Paez E, Aznar L, Gervas J. March 2001. Journal of Bone and Mineral Metabolism 19(2):97-101. DOI: 10.1007/s007740170047

· Effects of Potassium Bicarbonate Supplementation on Axial and Peripheral Bone Mass in Rats on Strenuous Treadmill Training Exercise. Rico H, Aznar L, Hernandez ER, Gervas October 1999. Calcified Tissue International 65(3):242-5. DOI: 10.1007/s002239900691

· “Nasopharyngeal Carcinoma Onset as a Brain Stem Syndrome and Cisplatin Neuropathy.” Aznar Garcia L., Hermando Requejo V., Perez Torrubia A.Oncology Review,2001;3(5):272-273.

· “Radioterapia del Cancer de Prostata.” Aznar Garcia L. Cancer Review 2004; 18(2): 55-65.

· “Facial Cutaneous Metastases of Rectal Adenocarcinoma.” Aznar Garcia L., Carrillo Gomez R., Blasco Martinez A., Cerezo Padellano L., Oncology Review, 2004; 6(7): 443-444.

· “Radioterapia Conformada en Tres Dimensiones (RC3D) y Radioterapia de Intesidad Modulada (IMRT) en Cancer de Prostata Localizado.” Caballero B., Aznar Garcia L., Sanchez G., Garcia R

Book Chapters

Nutricion del Paciente Con Cancer.” Chapter 26. Author: Luis Aznar Garcia. As appeared in “Nutriguia Manual de Nutricion Clinica en Atencion Primaria.” First Edition. October 2000. Ch. 26; 225-233. Requejo AM, Ortega RM, Ed. Editorial Complutense.

 

“Tratamiento Radioterapico del Cancer de Prostata Localizado y Localmente Avanzado.” Chapter 2. Authors: Rodrigo García-Alejo Hernández y Luis Aznar García. As appeared in “Monografias de Oncologia Medica 2005. Abordaje Terapeutico del Cancer de Prostata.” 2005. Ch. 2;23-50.

 

“Papel de la Radioterapia en el Cancer de Pulmon.” Chapter 12. Authors: Rodrigo García-Alejo Hernández y Luis Aznar García. As appeared in “Cancer no Microcitico de Pulmon: Un Reto para el Siglo XXI.” González Barón, de Castro J. Ed: Ars Medica. 2006. Ch. 12; 225-245.

 

“Aspectos Clinicos de Radioterapia y nuevas tecnicas.” Chapter 21.Authors: Luis Aznar García, R. García-Alejo Hernández, G. Sanchez Rodillo y J. Blanco Rodríguez. As appeared in “Gonzalez Baron. Oncologia Clinica: 3ª Edición”. Vol. 1: Patologia General. 2008.

 

“Nutricion del Paciente Con Cancer.” Chapter 26. Author: Luis Aznar Garcia. As appeared in “Nutriguia Manual de Nutricion Clinica en Atencion Primaria.” Second Edition. April 2014. Ch. 26; 225-233. Requejo AM, Ortega RM, Ed. Editorial Panamericana.

 

“Fighting lung cancer with conventional therapies”. Chapter 16. “Treatment for early stage small cell lung cancer”. S Ahmed, M Chauhan, L Aznar-Garcia and D Marquez. Ed Nova. 2015: 289-312..

 

International Scientific Oncology/Radiotherapy Societies Membership and Medical Journals Editor

 

· International Stereotactic Radiosurgery Society (ISRS) 2017 – Present

 

· European Society of Radiology and Oncology Member (ESTRO). 2012 – Present

 

· European Society of Medical Oncology (ESMO) 2014 – Present

 

· Royal College of Radiologist Membership (RCR) 2013 – Present

 

· Chair Clinical Oncology Spanish Society (SEOC) 2015 – Present

 

· SEOR Work Groups Member Breast, Lung, CNS Cancer and SBRT and H&NC.2010 – Present

 

· Associate Editor of “Clinical and Translational Oncology.” 2006 – Present

 

· Associate Editor of “Cancer Investigation”. 2013 – Present

 

· Associate Editor American Journal Biomedicine 2013 – Present

 

· Licensed Radioactive Installation Supervisor. 2006 – Present

 

· Radiation Oncology Spanish Society Member (SEOR). 1998 – Present

 

· General Medical Council Full Registration and Specialist Register (nº:7450672) 15/8/2013